News
Title
Provider
09/27/2017
Healios: Presentation at Cell and Gene Meeting on the Mesa
Kobe Biomedical Innovation Cluster Department, Kobe City
Press release 09/26/2017
Sysmex Launches the Revohem FVIII Chromogenic, a Coagulation Factor VIII Assay Reagent -Helping to Diagnose and Assist in Treatment of Hemophilia A-
Kobe Biomedical Innovation Cluster Department, Kobe City
Press release 09/19/2017
Sysmex Signs Agreement with Mongolia’s Ministry of Health to Provide External Quality Assessment Support in the Field of Blood Morphology Testing
Kobe Biomedical Innovation Cluster Department, Kobe City
Press release 09/13/2017
Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Second Consecutive Year
Kobe Biomedical Innovation Cluster Department, Kobe City
Press release 08/10/2017
Sysmex, Hyogo Pharmaceutical Society and Shinkai Transport Systems Enter Agreement to Cooperate on Disaster Relief Activities
Kobe Biomedical Innovation Cluster Department, Kobe City
Press release 07/31/2017
WHO Kobe Centre: “Kobe Model” of Early Detection and Management for Dementia
Kobe Biomedical Innovation Cluster Department, Kobe City
Press release 07/31/2017
Sysmex Completes Expansion of Reagent Factory in the United States -Reagent Production Capacity Boosted to 1.8 Times Former Level in Line with Expected Increase in Demand in the Americas-
Kobe Biomedical Innovation Cluster Department, Kobe City
Press release 07/26/2017
Santen and TRACON Announce Initiation of a Phase 2a Study of DE-122 for the Treatment of Wet Age-Related Macular Degeneration
Kobe Biomedical Innovation Cluster Department, Kobe City
Press release 07/25/2017
Sumitomo Dainippon Pharma Announces Investment in DEFTA Healthcare Technologies, L.P.
Kobe Biomedical Innovation Cluster Department, Kobe City
Press release 07/04/2017
RIKEN AICS: New system promises more rapid and accurate prediction of rainfall
Kobe Biomedical Innovation Cluster Department, Kobe City